A rare case of prurigo pigmentosa in a Danish sibling couple
FDAs own safety-risk pages on bulk drug substances proposed for compounding flag concerns for several peptides popular in online circles, including issues such as limited human safety information, immunogenicity concerns, peptide-related impurities, difficult characterization, and reported serious adverse events for some molecules
Compare this to Kybella, the FDA-approved deoxycholic acid treatment
References to supplements and products do not imply treatment, prevention or cure of any medical conditions
In: Hossain MA, Ahammed GJ, Kolbert Z, El-Ramady H, Islam T, Schiavon M (eds) Selenium and Nano-Selenium in Environmental Stress Management and Crop Quality Improvement
The relative influences of other factors on discontinuation are unclear, including changes in insurance coverage, high outofpocket costs, medication shortages [75], or false cessation due to switching to compounded (pharmacy prepared) GLP1s